AEON: the balance sheet

MyFinsight

For the year ending 2025-12-31, AEON has $5,560K in assets. $60,587K in debts. $3,006K in cash and cash equivalents.

Balance Sheets	2025-12-31
Cash and cash equivalents	3,006
Prepaid expenses and other current assets	392
Total current assets	3,398
Property and equipment, net	162
Operating lease right-of-use asset	1,052
Other assets	948
Total assets	5,560

Accounts payable	942
Accrued clinical trials expenses	1,426
Accrued compensation	2,872
Other accrued expenses	1,657
Total current liabilities	6,897
Convertible notes at fair value, including related party amount of 34,600 and 11,689, at december 31, 2025 and 2024, respectively	34,600
Operating lease liability	893
Derivative liability	14,879
Warrant liabilities	3,276
Contingent consideration liability	42
Total liabilities	60,587
Class a common stock, 0.0001 par value 1,040,000,000 and 500,000,000 shares authorized at december 31, 2025 and 2024, and 12,105,902 and 555,511 shares issued and outstanding at december 31, 2025 and 2024, respectively	9
Additional paid-in capital	415,783
Accumulated deficit	-470,819
Total stockholders' deficit	-55,027
Total liabilities and stockholders' deficit	5,560

Unit: Thousand (K) dollars (except for numbers of shares and EPS).